DARTBAC prepares the Netherlands for the post-antibiotic era caused by Anti Microbial Resistance (AMR)

Collectively, we possess the entire knowledge-chain for development of new material technologies to combat AMR.
Connect with us:

Numbers and facts

The danger AMR poses for public health

When bacteria become resistant to antibiotics it greatly complicates and lengthens the treatment, dramatically increasing the incidence of further complications or even, ultimately, death.

1.5M

It is estimated that 1.5 million people die every year as a result of AMR

2.1M

Within the USA alone 2.1 million people sustained illness due to AMR in 2010

Learn more about amr

What is Anti Microbial Resistance?

When the antibiotic dose becomes too low, bacteria can develop resistance to the antibiotic and are no longer susceptible to it.
Infection a major clinical challenge
Infection is the invasion of body tissues by disease-causing microorganisms, their multiplication, and the reaction of host tissues to the infectious microorganisms (e.g. bacteria, viruses, fungi, or parasites).
The problem worsens even further
Microorganisms acquire antibiotic resistance due to chromosomal DNA mutations and horizontal transfer of genetic material.
Bacteria become resistant to antibiotics
They become so-called superbugs
Infections become more dangerous and in some cases even lethal
More explainations in the WHO video’s
Learn more >

Project aims

What are our project goals?

DARTBAC will, from a material perspective, develop new antimicrobial technologies that are not based on antibiotics to target infection prevention.
Learn more >

Create societal AMR awareness

Develop new antimicrobial technologies

Optimize AB efficacy with combination therapy

Standardize testmodels for faster clinical implementation

Project News

21 November 2022

Don’t forget to attend tomorrow; the lecture of our principal investigator about #amr. He will explain more about the solutions that we are working on in the project #Dartbac he leads. #WAAW2022 twitter.com/caphri_um/stat…

21 November 2022

Don’t forget to attend tomorrow; the lecture of our principal investigator’s lecture about #amr. He will explain more about the project #Dartbac hè leads. #WAAW2022 twitter.com/caphri_um/stat…

21 November 2022

Goed dat er meer aandacht komt voor #AMR en de gevaren van antibiotica. Dank je ⁦@ADnl

Dit is waarom het niet goed is regelmatig antibiotica te slikken: ‘Het is geen wondermiddel’ | Gezond | AD.nl ad.nl/gezond/br-br-d…

Follow DARTBAC on Twitter

Get involved

What can you do to combat AMR?

Take care of optimal hygiene

Be informed when using antibiotics

Ask your doctor for alternatives

Finish your AB prescriptions

Healthcare professionals

Are you working in the field and want to learn more about the project?
HCP info

Our partners

An interdisciplinary consortium

9 Academic partners, 10 industry partner, the Dutch Institute for Public Helath and te Environment (RIVM) work together with 4 cooperation partners ReumaNederland health fund, Dutch Orthopaedic Association (NOV), Dutch Knowledge-institute Medical Specialists and webbased AMR platform AMR-Insights to combat AMR. This project received funding from the NWO (NWA-ORC)
Menu